Hope Medicine
Series B in 2024
Hope Medicine is a biopharmaceutical company focused on researching, developing, and commercializing innovative drugs to enhance the quality of life for various common male and female diseases. The company specializes in translational medicine and aims to address significant health challenges by leveraging global research initiatives. Hope Medicine is engaged in the development of monoclonal antibodies, protein-based therapies, and other drug formulations targeting endocrine, cardiovascular, and metabolic diseases. Through its efforts, the company seeks to provide underserved patient populations with access to effective and affordable treatments, ultimately improving their health outcomes.
Awfar is a B2B SaaS platform that digitizes retail on-demand order fulfillment. It offers modules for communication channels, e-commerce solutions, CRM, inventory management, branch management, and delivery systems. All modules are cloud-based and accessible via PC, tablet, or mobile devices. Awfar also provides a robust reporting system and customizable permissions structure.
CiDi focuses on the technological innovation and execution required to create practical, self-driving commercial vehicles and products. The company has obtained public road testing permits for SAE Level 4 trucks capable of exceeding 100km/h on highways. During the first two years, the company completed numerous projects for various commercial and special vehicles. CiDi, for example, has delivered unmanned and remote-controlled mining trucks to mining areas for operation, as well as operated intelligent buses on open city streets and mass-produced V2X-connected vehicles and equipment in multiple cities and regions.
Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.
Slope Finance
Series A in 2022
Slope Finance is a developer of a mobile decentralized exchange and wallet platform focused on enhancing user experience in the cryptocurrency space. Built on the Solana blockchain, Slope Finance enables users to engage in decentralized finance, utilize Solana Pay, and manage non-fungible tokens through a visually appealing interface. The platform features a decentralized automated full limit order book, allowing for fast crypto trading, while also providing tools for users to create or import Ethereum and Solana wallets. With an emphasis on speed and near-zero transaction fees, Slope Finance aims to simplify the management and trading of digital assets, making it accessible for both seasoned traders and newcomers.
SyMap Medical
Series E in 2021
SyMap Medical is focused on the development and manufacturing of innovative medical devices aimed at treating hypertension and related diseases, including heart failure, arrhythmia, and severe asthma. The company specializes in a proprietary catheter-based renal mapping and ablation system that utilizes radiofrequency (RF) ablation technology. This system is designed for renal denervation therapy, which involves mapping and selectively ablating renal nerves to effectively manage hypertension. Through its advanced technology platform, SyMap Medical aims to address significant health challenges associated with major cardiovascular and respiratory conditions.
Uniskin is a cosmetics brand that provides skin-care products suitable for the local area and people.
HAI ROBOTICS
Series C in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a range of solutions, including intelligent goods-to-person and smart in-plant logistics systems, tailored for diverse operational scenarios. As a pioneer in this field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, which has since evolved through continuous research and development. The HAIPICK system enhances warehouse efficiency significantly, reportedly increasing operational efficiency by three to four times and storage density by 80% to 130%. HAI ROBOTICS holds multiple patents and serves a growing list of clients, providing flexible and customizable automation solutions to optimize warehousing operations and improve overall productivity.
Inmagene Biopharmaceuticals
Series C in 2021
Inmagene Biopharmaceuticals Co. Ltd. is a Shanghai-based biopharmaceutical company founded in 2019, specializing in the research and pre-clinical development of therapies for immunology-related diseases. The company focuses on creating innovative drug candidates that address unmet medical needs globally, employing a strategy known as "Borderless Innovation." Inmagene has developed a diverse pipeline, including IMG-020, a protein drug designed to target IL-17A, which utilizes a combination of Affibody's protein therapeutics platform and Albumod technology to enhance potency and extend half-life. In addition to IMG-020, the company boasts several clinical-stage assets and multiple preclinical candidates aimed at improving pharmacokinetic and pharmacodynamic properties, safety profiles, and dosing convenience for patients. With additional offices in Hangzhou and Beijing, Inmagene is dedicated to advancing drug development through cutting-edge technology and a commitment to global collaboration in the fight against immunological diseases.
CiDi focuses on the technological innovation and execution required to create practical, self-driving commercial vehicles and products. The company has obtained public road testing permits for SAE Level 4 trucks capable of exceeding 100km/h on highways. During the first two years, the company completed numerous projects for various commercial and special vehicles. CiDi, for example, has delivered unmanned and remote-controlled mining trucks to mining areas for operation, as well as operated intelligent buses on open city streets and mass-produced V2X-connected vehicles and equipment in multiple cities and regions.
BlissBio is a biopharmaceutical company dedicated to the development of innovative drugs for tumor targeting and immunotherapy. The company specializes in creating pharmaceuticals that utilize antibody-drug conjugate (ADC) and site-specific conjugate technology platforms, which are supported by independent intellectual property rights. These platforms enable BlissBio to develop and industrialize advanced anti-tumor therapies aimed at improving treatment outcomes for cancer patients. Through its focus on targeted therapies, BlissBio aims to contribute significantly to the field of oncology with its bio-innovative drug solutions.
Chime Biologics
Series A in 2021
Chime Biologics Limited is a Contract Development and Manufacturing Organization (CDMO) based in Wuhan, China, specializing in biopharmaceutical development and manufacturing services. Established in 2013, the company offers a wide range of services, including drug substance and drug product manufacturing, cell line development, and protein science characterization. It also supports clients with technical transfer, regulatory guidance, and project management to ensure a comprehensive solution throughout the biopharmaceutical development lifecycle. Chime Biologics focuses on delivering customer-centric, cost-effective, high-quality services that cater to the evolving needs of the biopharmaceutical industry, facilitating early-stage development through late-stage clinical research and commercial production.
Didi Freight
Series A in 2021
DiDi Freight is a freight service platform that focuses on intra-city shipping and moving solutions. The company offers a variety of vehicles to meet diverse transportation needs, ensuring each delivery is fully insured and drivers are rigorously screened. DiDi Freight aims to provide transparent pricing and reliable services to enhance the shipping experience for customers.
Windtree Therapeutics
Post in 2019
Windtree Therapeutics is a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases. Its proprietary technology platform includes KL4 surfactant, structurally similar to endogenous pulmonary surfactant, and novel drug-delivery technologies enabling noninvasive administration via aerosolization.
I-Mab Biopharma
Series C in 2019
I-Mab Biopharma (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, with additional offices in Beijing and Rockville, Maryland. Founded in 2016, the company focuses on the discovery, development, and commercialization of innovative biologics aimed at addressing significant unmet medical needs, particularly in the fields of immuno-oncology and immuno-inflammation. I-Mab's diverse drug pipeline targets various therapeutic areas, including multiple myeloma, autoimmune diseases, pediatric growth hormone deficiency, and several cancer indications such as head and neck cancer. Key candidates in its portfolio include Uliledlimab, an antibody for solid tumors, along with Ragistomig and Givastomig, highlighting the company's commitment to developing transformative therapies for patients.
Dingdong Maicai
Series B in 2019
Dingdong Maicai is a leading Chinese community-based online retail platform specializing in fresh produce, founded in 2014 and headquartered in Shanghai. The company focuses on enhancing the fresh food consumption experience through its technologically driven service model, which includes direct procurement from producers, efficient pre-warehouse distribution, and rapid home delivery within 29 minutes. It offers a wide range of products, including fresh vegetables, meat, seafood, and other daily necessities, accessible via the Dingdong Fresh app and mini-programs. Operating in major cities like Shanghai, Beijing, Shenzhen, Hangzhou, and Suzhou, Dingdong Maicai is recognized as one of the fastest growing on-demand e-commerce companies in China, supported by an extensive self-operated fulfillment network.
Bangsun Technology
Series C in 2019
Bangsun Technology, based in Hangzhou, China, specializes in developing online payment security software tailored for domestic internet trading companies and financial institutions. Founded in 2010, the company offers a range of solutions, including banking and tripartite payment solutions, as well as services for bank cards, credit cards, and securities. Its product lineup features real-time transaction anti-fraud systems, Internet credit services, data analytics through machine learning, device fingerprinting, and anti-money laundering solutions. Additionally, Bangsun Technology focuses on providing comprehensive risk management services, including application anti-fraud measures and robot defense, to enhance the security of financial transactions.
New Horizon Health
Series C in 2019
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.
Shanghai Zhangmen Education Technology Co., Ltd. operates Zhangmen, an online tutoring platform that offers personalized tutoring courses for primary and middle school students aged eight to 18. Founded in 2014 and based in China, Zhangmen allows students to connect with highly qualified teachers who have graduated from prestigious universities such as Tsinghua, Peking University, and Fudan University. The platform provides a range of educational services, including one-on-one tutoring and comprehensive online education classes. Through its online and mobile applications, Zhangmen aims to enhance the learning experience by offering tailored educational support to meet the individual needs of each student.
Crossbar
Venture Round in 2018
Crossbar Inc. is a technology company based in Santa Clara, California, founded in 2008, specializing in the development and licensing of resistive RAM (ReRAM) technology. This innovative memory solution enables the storage of up to one terabyte of data on a chip the size of a postage stamp, offering significant advantages in terms of power efficiency and performance. Crossbar's ReRAM products cater to a variety of applications, including consumer electronics, mobile devices, enterprise storage, cloud computing, and industrial sensors. By providing a new approach to data storage and processing, Crossbar's technology allows designers to rethink traditional memory paradigms, facilitating the integration of compute and storage subsystems in both edge and cloud environments. The company's advancements are positioned to transform the landscape of non-volatile memory and enable new capabilities in electronics innovation.
Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the design and development of tissue-integrated sensors and biosensors aimed at improving diabetes management. Founded in 2009, the company focuses on creating biointegrated sensors that allow individuals to monitor their biochemical data in real-time, facilitating better management of personal health and chronic diseases. Profusa's technology aims to seamlessly integrate with the body, providing continuous, clinical-grade data that enhances health outcomes. In addition to its sensor technology, the company has developed software that offers biofeedback to support chronic disease management and promote healthy living.
Chemclin
Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its service offerings encompass clinical inspection instruments, various types of auxiliary reagents, technical support, management and certification, as well as the operation of independent medical laboratories. Chemclin is committed to introducing advanced diagnostic products and services to the Chinese market, thereby enhancing the capabilities of clinical diagnostics in the region.
TalkingData
Series E in 2018
TalkingData is a Beijing-based company established in 2011, specializing in advanced data analytics for the Chinese mobile internet market. It offers a suite of big data products, including scalable data mining, deep data analytics, industry benchmarking reports, and market insights. With nearly 1.5 billion devices covered, TalkingData serves 80% of China's top app developers, helping them track metrics, analyze user data, and optimize monetization strategies. The company collaborates closely with major distribution channels and ad networks, and is expanding into cross-border cooperation with financial industries.
Renrui Human Resources Technology Holdings
Series D in 2018
Renrui Human Resources Technology Holdings is a Chinese provider of integrated human resources services, delivering flexible staffing, professional recruitment, and other HR solutions. It operates an online-to-offline recruitment platform in the flexible staffing market and offers talent outsourcing, senior talent management, onboarding and on-site recruitment, as well as business process outsourcing covering performance and operations management, training management, information security, and scheduling. The company also provides labor dispatch and corporate training services alongside digital technology and cloud based HR solutions. Its flexible staffing business emphasizes general service outsourcing, digital technology, digital operations, and customer services. Founded in 2010 and headquartered in Chengdu, Renrui serves customers across China.
Eden Biologics
Convertible Note in 2018
Eden Biologics is a biopharmaceutical company that focuses on developing biosimilars and providing contract development and manufacturing services to clients and partners in the biopharmaceutical industry. The company specializes in producing complex dosage forms, including oral solids, liquids, semi-solids for both prescription and over-the-counter products, as well as macromolecule biologics. Eden Biologics offers expertise in manufacturing biologics from cell line development through commercial production, with a global and regional regulatory affairs knowledge base to ensure affordability and accessibility of biopharmaceuticals worldwide.
Youdao, established in 2006, specializes in internet technology services, focusing on content, community, communication, and commerce. It offers a range of learning tools including Youdao Dictionary, Youdao Cloudnote, and translation tools, along with smart devices like the Youdao Smart Pen. Headquartered in Hangzhou, China, Youdao operates as a subsidiary of NetEase.
Founded in 2016, Pony.ai develops artificial intelligence software for autonomous mobility deployment, focusing on manufacturing automated vehicles and offering public-facing Robotaxi services. The company operates fully driverless robotaxis through the PonyPilot mobile app in major Chinese cities.
Meicai is a technology company that facilitates direct online sourcing and distribution of agricultural products. It aims to streamline the agriculture supply chain by connecting farmers directly with restaurants and food service businesses, reducing intermediaries, improving delivery efficiency, and ensuring consistent produce supply.
Keyssa, Inc., established in 2009 and headquartered in Campbell, California, specializes in developing and manufacturing contactless connectors and wireless semiconductors. Utilizing millimeter-wave technology, the company's flagship product, Kiss Connectivity, enables secure, instantaneous, and high-speed data transfer between devices in close proximity. This tiny, solid-state system eliminates the need for traditional metal connectors, cables, and wireless networks, offering a protocol-agnostic, EHF transmission solution. Keyssa's products cater to a wide range of industries, including mobile phones, displays, automotive, robotic surgery, factory automation, and data centers. The company aims to simplify and enhance device-to-device data flow, freeing product designers and consumers from conventional connectivity constraints.
Gamida Cell
Series F in 2017
Gamida Cell Ltd., established in 1998 and headquartered in Jerusalem, Israel, is a clinical-stage biopharmaceutical company focused on developing advanced cell therapies to treat blood cancers and serious blood diseases. The company's lead product candidate, omidubicel, is an expanded hematopoietic stem cell therapy derived from umbilical cord blood, currently in Phase 3 studies for patients with high-risk hematologic malignancies and severe aplastic anemia. Additionally, Gamida Cell is developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase 1/2 trials for relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Both candidates leverage the company's proprietary expansion platform based on nicotinamide to enhance cell properties and therapeutic potential.
Souche, founded by Yao Junhong in December 2012, is a prominent automotive new retail platform in China. The company has attracted significant investments, raising over $1.2 billion by August 2018 from notable organizations such as Alibaba Group and Ant Financial Services Group. Recognized in the 2017 New Global Unicorns Ranking by PitchBook, Souche aims to be a central intelligence hub for the automotive industry. Over the years, it has developed an integrated automotive retail ecosystem that includes various businesses. These encompass Tangeche, an automotive financial leasing platform; Chehang168, a B2B industrial chain service platform; Cheyipai, an online used-car trading platform; and TIHD, a car-sharing service. Additionally, Souche offers SaaS products for used-car dealers through Dafengche and operates a new-car dealership network called Maicheguanjia. The company also provides ERP systems for dealership groups and integrated supply chain logistics services. Souche is often referred to as "the Alibaba of the Chinese automotive industry."
iQIYI is a leading Chinese online entertainment service provider, offering a wide range of content including internet video, live broadcasting, online literature, animations, e-commerce, and social media platforms. It operates on a subscription-based model with additional revenue from ads, content distribution, gaming, and IP licensing. iQIYI competes directly with major players such as Tencent Video, Youku, MangoTV, and Bilibili.
NextVR, Inc. is a technology company based in Laguna Beach, California, founded in 2009, specializing in the development of video capture technology for virtual reality experiences. The company focuses on enabling the transmission of live and on-demand virtual reality content in high-definition quality, primarily for sporting events, concerts, and cinematic productions. NextVR's platform captures, compresses, and transmits immersive VR content, allowing users to experience events as if they were physically present. With over 26 patents granted or pending, the company aims to make virtual reality a mainstream medium, leveraging strategic partnerships with industry leaders like Samsung and Oculus. As a subsidiary of Apple Inc., NextVR continues to innovate in the realm of virtual reality, enhancing accessibility and engagement for audiences worldwide.
Post-Quantum
Series A in 2016
Post-Quantum is a cybersecurity company established to address the emerging threat posed by quantum cryptanalysis. It specializes in developing advanced systems and products that safeguard sensitive data and workflows. The company offers biometric authentication solutions and a secure encrypted communications platform for both mobile and desktop applications. These offerings are designed to protect business information by ensuring data confidentiality, authenticity, and access control. Additionally, Post-Quantum has expanded its services to include Identity and Access Management (IAM) and blockchain-enabled enterprise software as a service (SaaS), further enhancing its capabilities to help clients operate safely and securely in an increasingly digital landscape.
Pharmaron
Private Equity Round in 2015
Pharmaron offers comprehensive research, development, and manufacturing services across drug discovery, preclinical, and clinical phases for small molecules, biologics, and cell & gene therapies.
KingMed Diagnostics
Private Equity Round in 2015
KingMed Diagnostics is a leading independent clinical laboratory in China, founded in 1994. It provides outsourced medical examination and pathology diagnosis services, and offers a wide range of tests including mass spectrometry, immunology and biochemical luminescence testing, genetic testing, physical and chemical analyses, and pathology diagnosis. The company operates about 50 centralized laboratories as of 2024 and offers more than 4,000 test items. More than 90% of its revenue comes from clinical diagnostics. KingMed has been expanding its cold chain logistics to support specimen handling and distribution, and its service network covers the most densely populated areas of China, enabling broad access to diagnostic testing.
UCloud Information Technology
Series C in 2015
UCloud Information Technology specializes in cloud computing technology, offering a range of solutions that include Infrastructure as a Service (IaaS), Platform as a Service (PaaS), and big data and artificial intelligence services. Founded in 2011 and headquartered in Shanghai, China, the company develops its own cloud computing products, such as UCloud Physical Host, UCloud Host, and UCloud Load Balancer, which facilitate resource management and application data distribution. UCloud also provides services like UCloud Disk for storage, UCloud DataBase for data management, and cloud security solutions. The company serves various sectors, including e-commerce, online education, and digital marketing, delivering both public and private cloud solutions tailored to meet diverse customer needs. UCloud’s commitment to independent research and development underlines its position as a secure and neutral cloud service provider.
FinVolution Group
Series C in 2015
FinVolution Group, formerly PPDai, operates an online platform that facilitates peer‑to‑peer small unsecured loans in China. The company emphasizes a secure, high‑performance network built on innovative technology and ethical principles. It standardizes personal debit and credit behaviors, aiming to deliver benefits to both lenders and borrowers. Founded in August 2007 by individuals from prominent firms, FinVolution Group has positioned itself as a key player in China’s fintech lending ecosystem.
Mediheal
Private Equity Round in 2015
Mediheal is a beauty brand that offers everyday sheet masks. The company approaches beauty scientifically, collaborating with leading dermatologists, scientists, and aestheticians to develop incredibly powerful all-in-one skin solutions. By redefining sheet masks as a flexible, expert, and cutting-edge treatment option, Mediheal has revolutionized the industry.